在老年患者中使用Cangrelor:意大利对CANGrELOr研究的前性研究的发现
Piera Capranzano1, Paolo Calabrò2, Giuseppe Musumeci3
1Cardiology Division, Policlinico Hospital, University of Catania, Catania, Italy.
The American journal of cardiology
|December 24, 2024
概括
对于接受皮肤冠状动脉干预 (PCI) 的老年急性冠状动脉综合征患者来说,康格罗尔转换为口服P2Y12抑制剂是安全的. 出血风险相似,但年轻患者的主要不良心脏事件较低.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 对于老年患者使用康格雷勒的结果数据有限.
- 老年人急性冠状动脉综合征 (ACS) 管理需要仔细考虑抗血栓策略.
- 穿皮冠状动脉干预 (PCI) 是ACS患者常见的复血管化方法.
研究的目的:
- 评估ACS患者年龄分层子组 (75岁以上与75岁以下) 的出血和缺血结局.
- 评估PCI后从香草转换为口服P2Y12抑制剂的安全性和有效性.
- 在老年亚组中分析80岁以上患者的结局.
主要方法:
- 对意大利关于鱼的前性研究 (ARCANGELO) 的后期分析.
- 接受ACSPCI治疗的患者分为老年 (≥75岁) 和年轻 (<75岁) 两组.
- 出血 (出血学术研究联盟标准) 和缺血性结局 (主要心脏不良事件) 在PCI后30天进行了比较.
主要成果:
- 年轻 (4.6%) 和老年 (7.4%) 患者之间的整体出血率没有显著差异 (p=0.1179).
- 年轻患者 (0.9%) 的重大心脏不良事件明显低于老年患者 (3.3%) (p=0.0170).
- 在PCI后48小时内发生的手术内血栓事件在两个年龄组中发生的比例相似 (1.4%对1.4%,p=1,000).
结论:
- 从康格罗尔转换为口服P2Y12抑制剂对于接受PCI的老年ACS患者来说,是一种安全有效的抗血栓治疗策略.
- 这些发现支持在老年人群中使用这种策略的常规临床实践.
- 虽然出血风险相似,但需要对老年患者的缺血事件进行仔细监测.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.3K
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
4.8K
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
453
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
453
01:16Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
1
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
1
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608